{"filing": {"accession": "0001683168-26-006570", "cik": "0001081938", "ticker": "CPMD", "company_name": "CANNAPHARMARX, INC.", "form_type": "10-Q", "filing_type": "10-Q", "filing_date": "2026-08-18", "accepted_datetime": null, "acceptance_datetime": null, "accepted_at": null, "primary_doc_url": "https://www.sec.gov/Archives/edgar/data/1081938/000168316826006570/0001683168-26-006570-index.htm", "filing_url": "https://www.sec.gov/Archives/edgar/data/1081938/000168316826006570/0001683168-26-006570-index.htm", "period_of_report": "2026-06-30"}, "html_url": "/api/filings/000168316826006570/stream", "exhibits": [{"exhibit_number": "31.1", "exhibit_type": "31", "description": "Certification of Chief Executive Officer required by Rule 13a-14(a) under the Exchange Act (filed herewith).", "filename": "cannapharmarx_ex3101.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1081938/000168316826006570/cannapharmarx_ex3101.htm", "category": "other", "incorporated_by_reference": false}, {"exhibit_number": "31.2", "exhibit_type": "31", "description": "Certification of Chief Financial Officer required by Rule 13a-14(a) under the Exchange Act (filed herewith).", "filename": "cannapharmarx_ex3102.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1081938/000168316826006570/cannapharmarx_ex3102.htm", "category": "other", "incorporated_by_reference": false}, {"exhibit_number": "32", "exhibit_type": "32", "description": "Certification of Principal Executive, Financial and Accounting Officer pursuant to 18 U.S.C Section 1350, as adopted pursuant to Section 906 of Sarbanes-Oxley Act of 2002 (filed herewith).", "filename": "cannapharmarx_ex3200.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1081938/000168316826006570/cannapharmarx_ex3200.htm", "category": "other", "incorporated_by_reference": false}, {"exhibit_number": "2.1", "exhibit_type": "2", "description": "Amended and Restated Membership Interest Purchase Agreement, dated November 22, 2023", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/0001081938/000168316823008658/canna_ex0201.htm", "category": "other", "incorporated_by_reference": true}, {"exhibit_number": "3.1", "exhibit_type": "3", "description": "Bylaws adopted 12/31/10", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1081938/000107258814000014/ex3-1b.txt", "category": "incorporation", "incorporated_by_reference": true}, {"exhibit_number": "3.2", "exhibit_type": "3", "description": "Certificate of Amendment of Certificate of Incorporation dated 10/22/14", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1081938/000107258814000106/ex3-1.txt", "category": "incorporation", "incorporated_by_reference": true}, {"exhibit_number": "3.3", "exhibit_type": "3", "description": "Certificate of Designation of Preferences, Rights and Limitation of Series C Convertible Preferred Stock", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1081938/000165495425004122/canna_ex33.htm", "category": "incorporation", "incorporated_by_reference": true}, {"exhibit_number": "4.1", "exhibit_type": "4", "description": "Letter Agreement between the Company and Koze Investments, LLC and Amir Tal regarding Allocation of Revenue from IMC Cannabis Transaction dated March 17, 2025", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1081938/000165495425005808/isdr_ex41.htm", "category": "debt", "incorporated_by_reference": true}, {"exhibit_number": "4.2", "exhibit_type": "4", "description": "Security And Royalty Agreement between the Company and Koze Investments, LLC dated March 17, 2025", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1081938/000165495425005808/isdr_ex42.htm", "category": "debt", "incorporated_by_reference": true}, {"exhibit_number": "4.3", "exhibit_type": "4", "description": "Amended and Restated Lease dated January 1, 2025", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1081938/000165495425005808/isdr_ex43.htm", "category": "debt", "incorporated_by_reference": true}, {"exhibit_number": "4.4", "exhibit_type": "4", "description": "Amendment No. 1 to Amended and Restated Secured Promissory Note; entered into with Koze Investments LLC and Amir Tal", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1081938/000165495425005808/isdr_ex44.htm", "category": "debt", "incorporated_by_reference": true}, {"exhibit_number": "4.5", "exhibit_type": "4", "description": "Amendment No. 1 to Amended and Restated Senior Secured Promissory Note; entered into with Koze Investments", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1081938/000165495425005808/isdr_ex45.htm", "category": "debt", "incorporated_by_reference": true}, {"exhibit_number": "4.6", "exhibit_type": "4", "description": "Secured Promissory Note dated February 26, 2025", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1081938/000165495425005808/isdr_ex46.htm", "category": "debt", "incorporated_by_reference": true}, {"exhibit_number": "4.7", "exhibit_type": "4", "description": "Transfer of 2323414 Alberta Ltd. to Elliot Zemel dated March 17, 2025", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1081938/000165495425005808/isdr_ex47.htm", "category": "debt", "incorporated_by_reference": true}, {"exhibit_number": "4.8", "exhibit_type": "4", "description": "Forbearance Agreement 2323414 Alberta (CPMD) - Formosa (June 2025)", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1081938/000165495425009626/canna_ex48.htm", "category": "debt", "incorporated_by_reference": true}, {"exhibit_number": "4.9", "exhibit_type": "4", "description": "Letter Agreement (Payment Schedule) - A. Tal", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1081938/000165495425011655/canna_ex11.htm", "category": "debt", "incorporated_by_reference": true}, {"exhibit_number": "4.10", "exhibit_type": "4", "description": "Payment Schedule (Payment Schedule) - Koze Investments", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1081938/000165495425011655/canna_ex11.htm", "category": "debt", "incorporated_by_reference": true}], "sections": [{"section_name": "part_1_item_1", "section_title": "Condensed Interim Consolidated Financial Statements (Unaudited)", "start_position": 3940, "end_position": 62960}, {"section_name": "part_1_item_2", "section_title": "Management\u2019s Discussion and Analysis of Financial Condition and Results of Operations/Plan of Operation", "start_position": 62960, "end_position": 108498}, {"section_name": "part_1_item_3", "section_title": "Quantitative and Qualitative Disclosures About Market Risk", "start_position": 108498, "end_position": 108717}, {"section_name": "part_1_item_4", "section_title": "Controls and Procedures", "start_position": 108717, "end_position": 115682}, {"section_name": "part_2_item_1", "section_title": "Legal Proceedings", "start_position": 115682, "end_position": 119268}, {"section_name": "part_2_item_1a", "section_title": "Risk Factors", "start_position": 119268, "end_position": 119443}, {"section_name": "part_2_item_2", "section_title": "Unregistered Sales of Equity Securities and Use of Proceeds", "start_position": 119443, "end_position": 120083}, {"section_name": "part_2_item_3", "section_title": "Defaults Upon Senior Securities", "start_position": 120083, "end_position": 121452}, {"section_name": "part_2_item_4", "section_title": "Mine Safety Disclosures", "start_position": 121452, "end_position": 121503}, {"section_name": "part_2_item_5", "section_title": "Other Information", "start_position": 121503, "end_position": 121774}, {"section_name": "part_2_item_6", "section_title": "Exhibits", "start_position": 121774, "end_position": 124529}], "tables": [{"table_index": 0, "table_type": "text", "caption": null, "header_text": "Delaware27-4635140"}, {"table_index": 1, "table_type": "text", "caption": null, "header_text": "Title of each classTrading Symbol(s)Name of each exchange on which registered"}, {"table_index": 2, "table_type": "text", "caption": null, "header_text": "Large accelerated filer\u2610Accelerated filer\u2610"}, {"table_index": 4, "table_type": "financial", "caption": null, "header_text": "Page"}, {"table_index": 7, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 10, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 13, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 16, "table_type": "text", "caption": null, "header_text": ""}, {"table_index": 19, "table_type": "financial", "caption": null, "header_text": ""}, {"table_index": 25, "table_type": "text", "caption": null, "header_text": "Schedule of inventory"}, {"table_index": 27, "table_type": "financial", "caption": null, "header_text": "Schedule of derivative liabilities"}, {"table_index": 28, "table_type": "financial", "caption": null, "header_text": "Schedule of weighted average inputs for derivative liabilities valuation"}, {"table_index": 31, "table_type": "financial", "caption": null, "header_text": "Schedule of related party transactions"}, {"table_index": 33, "table_type": "financial", "caption": null, "header_text": "Schedule of lease expense"}, {"table_index": 35, "table_type": "text", "caption": null, "header_text": "Schedule of professional fees"}, {"table_index": 36, "table_type": "text", "caption": null, "header_text": "(1)Invictus provides part-time CFO, financial reporting, and bookkeeping services to the Company. Mr. Oliver\nFoeste is the Managing Partner of Invictus."}, {"table_index": 38, "table_type": "financial", "caption": null, "header_text": "Schedule of interest expense"}, {"table_index": 39, "table_type": "financial", "caption": null, "header_text": "Schedule of imputed interest expense"}, {"table_index": 42, "table_type": "financial", "caption": null, "header_text": "Schedule of due to related parties"}, {"table_index": 43, "table_type": "financial", "caption": null, "header_text": "Schedule of accounts payable and accrued liabilities"}, {"table_index": 46, "table_type": "text", "caption": null, "header_text": "Schedule of outstanding principal"}, {"table_index": 59, "table_type": "text", "caption": null, "header_text": "Schedule of accrued interest to related parties"}, {"table_index": 61, "table_type": "financial", "caption": null, "header_text": "Schedule of interest expense related parties"}, {"table_index": 62, "table_type": "financial", "caption": null, "header_text": "Schedule of imputed interest expense related parties"}, {"table_index": 66, "table_type": "financial", "caption": null, "header_text": "Schedule of single operating segment"}, {"table_index": 72, "table_type": "financial", "caption": null, "header_text": "Three months endedJune 30,"}, {"table_index": 73, "table_type": "financial", "caption": null, "header_text": "\u00b7A $8,276 increase in royalty expense, reflecting higher royalty expense in the current period than in\nthe prior-year comparable period under the Koze agreement entered into on March 17, 2025."}, {"table_index": 74, "table_type": "financial", "caption": null, "header_text": "Three months endedJune 30,"}, {"table_index": 76, "table_type": "financial", "caption": null, "header_text": "\u00b7Change in the fair value of derivative conversion feature arising from variably priced convertible notes was a loss of $1,599,738\ncompared to $46,438 in the prior year comparable period. The primary "}, {"table_index": 77, "table_type": "financial", "caption": null, "header_text": "\u00b7Change in the fair value of obligation to issue shares was a gain of $758,999 compared to a gain of $46,033\nin the 2025 comparable period resulting from remeasurement of the obligation to issue share"}, {"table_index": 79, "table_type": "financial", "caption": null, "header_text": "Six months endedJune 30,"}, {"table_index": 82, "table_type": "financial", "caption": null, "header_text": "Six months endedJune 30,"}, {"table_index": 84, "table_type": "financial", "caption": null, "header_text": "\u00b7Change in the fair value of derivative conversion feature arising from variably priced convertible notes was a loss of $798,700\ncompared to a gain of $595,273 in the prior year comparable period. The"}, {"table_index": 85, "table_type": "financial", "caption": null, "header_text": "\u00b7A $448,406 decrease in interest expense is primarily attributable to a reduction in the interest rate\nfor certain loans to related parties, pursuant to a debt modification agreement entered into by t"}, {"table_index": 87, "table_type": "text", "caption": null, "header_text": "Six months endedJune 30,"}, {"table_index": 88, "table_type": "text", "caption": null, "header_text": "Average Price per Gram (CAD)*"}, {"table_index": 90, "table_type": "financial", "caption": null, "header_text": "Three months endedJune 30,Six months endedJune 30,"}, {"table_index": 92, "table_type": "text", "caption": null, "header_text": "Three months endedJune 30,Six months endedJune 30,"}, {"table_index": 93, "table_type": "text", "caption": null, "header_text": "(1)Invictus provides part-time CFO, financial reporting, and bookkeeping services to the Company. Mr. Oliver\nFoeste is the Managing Partner of Invictus."}, {"table_index": 95, "table_type": "text", "caption": null, "header_text": "Three months endedJune 30,Six months endedJune 30,"}, {"table_index": 96, "table_type": "text", "caption": null, "header_text": "Three months endedJune 30,Six months endedJune 30,"}, {"table_index": 97, "table_type": "financial", "caption": null, "header_text": "June 30,2026December 31,2025"}, {"table_index": 99, "table_type": "financial", "caption": null, "header_text": "June 30,2026December 31,2025"}, {"table_index": 101, "table_type": "text", "caption": null, "header_text": "June 30,2026December 31,2025"}, {"table_index": 114, "table_type": "text", "caption": null, "header_text": "June 30,2026December 31,2025"}, {"table_index": 115, "table_type": "text", "caption": null, "header_text": "Three months endedJune 30,Six months endedJune 30,"}, {"table_index": 117, "table_type": "text", "caption": null, "header_text": "Three months endedJune 30,Six months endedJune 30,"}, {"table_index": 120, "table_type": "financial", "caption": null, "header_text": "\u00b7pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions\nand dispositions of the assets of the Company;"}, {"table_index": 125, "table_type": "financial", "caption": null, "header_text": "Exhibit No.Description"}, {"table_index": 127, "table_type": "text", "caption": null, "header_text": "CannaPharmaRx, Inc."}], "exhibits_pending": false, "cdn_html": true, "response_time_ms": 27}